NCT00231738 - Protective Effect of EPA on Cardiovascular Events | Biotech Hunter

Enrollment

18,000

Participants

Timeline

Start Date

November 30, 1996

Study Completion Date

November 30, 2004

Conditions

Myocardial Infarction, Unstable Angina Pectoris, Sudden Cardiac Death, Stroke, Peripheral Artery Disease

Interventions

DRUG

Eicosapentaenoic acid ethyl ester(EPADEL Capsule 300 TM)

Trial Locations (1)

Kobe University Graduate School of Medicine Cardiovascular and Respiratory Medicine Division, Department of Internal Medicine, Kobe